Bioray Biotech Co., Ltd (TPEX:7561)

Market Cap	606.50M -17.2%
Revenue (ttm)	222.73M +10.4%
Net Income	32.25M +3,118.6%
EPS	1.09 +3,533.3%
Shares Out	29.59M
PE Ratio	18.81
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	38,000
Average Volume	16,059
Open	19.60
Previous Close	19.75
Day's Range	19.60 - 20.50
52-Week Range	19.50 - 32.10
Beta	0.22
RSI	37.56
Earnings Date	May 12, 2026

About Bioray Biotech

Bioray Biotech Co., Ltd engages in the production, research, and sells health foods, immune cell products, and precision testing services in Taiwan. It offers health care products, including various functional foods and supplements; medicinal fungi; immune cell products; and precision medicine services, such as immunology, cell division, and specialized laboratory testing. The company is also involved in the cell testing and storage business. Bioray Biotech Co., Ltd was founded in 2005 and is based in Tainan City, Taiwan.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2005
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 7561

Financial Performance

In 2025, Bioray Biotech's revenue was 222.73 million, an increase of 10.42% compared to the previous year's 201.71 million. Earnings were 32.25 million, an increase of 3118.56%.